These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 6319497

  • 1. Susceptibility of Adenovirus 2-transformed rat cell lines to natural killer (NK) cells: direct correlation between NK resistance and in vivo tumorigenesis.
    Sheil JM, Gallimore PH, Zimmer SG, Sopori ML.
    J Immunol; 1984 Mar; 132(3):1578-82. PubMed ID: 6319497
    [Abstract] [Full Text] [Related]

  • 2. Sensitivity of simian virus 40-transformed C57BL/6 mouse embryo fibroblasts to lysis by murine natural killer cells.
    Fresa KL, Karjalainen HE, Tevethia SS.
    J Immunol; 1987 Feb 15; 138(4):1215-20. PubMed ID: 3027174
    [Abstract] [Full Text] [Related]

  • 3. Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines.
    Wright SC, Bonavida B.
    J Immunol; 1984 Dec 15; 133(6):3415-23. PubMed ID: 6491292
    [Abstract] [Full Text] [Related]

  • 4. Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells.
    Johnson PW, Trimble WS, Hozumi N, Roder JC.
    J Immunol; 1987 Jun 01; 138(11):3996-4003. PubMed ID: 3495578
    [Abstract] [Full Text] [Related]

  • 5. Effect of altered membrane structure on NK cell-mediated cytotoxicity. II. Conversion of NK-resistant tumor cells into NK-sensitive targets upon fusion with liposomes containing NK-sensitive membranes.
    Roozemond RC, van der Geer P, Bonavida B.
    J Immunol; 1986 May 15; 136(10):3921-9. PubMed ID: 3701064
    [Abstract] [Full Text] [Related]

  • 6. An oligosaccharide biosynthetic defect in concanavalin A-resistant Chinese hamster ovary (CHO) cells that enhances NK reactivity in vitro and in vivo.
    Pohajdak B, Wright JA, Greenberg AJ.
    J Immunol; 1984 Nov 15; 133(5):2423-9. PubMed ID: 6481160
    [Abstract] [Full Text] [Related]

  • 7. Immunologic control of a retrovirus-associated murine adenocarcinoma. VIII. Corynebacterium parvum-activated natural killer cells as potent antibody-dependent cell-mediated cytotoxicity effectors.
    Weinhold KJ, Bolognesi DP, Matthews TJ.
    J Natl Cancer Inst; 1985 Oct 15; 75(4):717-24. PubMed ID: 3862904
    [Abstract] [Full Text] [Related]

  • 8. Role of tumor necrosis factor-alpha in E1A oncogene-induced susceptibility of neoplastic cells to lysis by natural killer cells and activated macrophages.
    Cook JL, May DL, Wilson BA, Holskin B, Chen MJ, Shalloway D, Walker TA.
    J Immunol; 1989 Jun 15; 142(12):4527-34. PubMed ID: 2723438
    [Abstract] [Full Text] [Related]

  • 9. An analysis of the sensitivity of somatic cell hybrids to natural killer cell- and natural cytotoxic cell-mediated lysis.
    Lin Y, Collins JL, Patek PQ, Cohn M.
    J Immunol; 1983 Sep 15; 131(3):1154-9. PubMed ID: 6604090
    [Abstract] [Full Text] [Related]

  • 10. Development of a murine lymphoma model system for the characterization of natural killer:tumor cell interactions.
    Smithson G, Wolcott RM, Chervenak R.
    Cancer Res; 1992 Aug 01; 52(15):4149-56. PubMed ID: 1638530
    [Abstract] [Full Text] [Related]

  • 11. Human oncogene-transfected tumor cells display differential susceptibility to lysis by lymphokine-activated killer cells (LAK) and natural killer cells.
    Lanza LA, Wilson DJ, Ikejiri B, Roth JA, Grimm EA.
    J Immunol; 1986 Oct 15; 137(8):2716-20. PubMed ID: 3489774
    [Abstract] [Full Text] [Related]

  • 12. Properties and characterization of a rat spleen cell-derived factor that induces resistance to natural killer cell lysis in YAC lymphoma cells.
    Saxena RK, Saxena QB, Adler WH.
    J Immunol; 1988 Sep 01; 141(5):1782-7. PubMed ID: 2457628
    [Abstract] [Full Text] [Related]

  • 13. A functional comparison of tumor cell killing by activated macrophages and natural killer cells.
    Roder JC, Lohmann-Matthes ML, Domzig W, Kiessling R, Haller O.
    Eur J Immunol; 1979 Apr 01; 9(4):283-8. PubMed ID: 467492
    [Abstract] [Full Text] [Related]

  • 14. Rat natural killer cell activity against lymphoid and nonlymphoid tumor cells and normal rat cell lines.
    Rees RC, Reynolds CW, Herberman RB.
    Cancer Res; 1983 Sep 01; 43(9):4248-52. PubMed ID: 6871862
    [Abstract] [Full Text] [Related]

  • 15. In vivo or in vitro selection for resistance to natural cytotoxic cell lysis selects for variants with increased tumorigenicity.
    Patek PQ, Lin Y, Collins JL, Cohn M.
    J Immunol; 1986 Jan 01; 136(2):741-5. PubMed ID: 3941271
    [Abstract] [Full Text] [Related]

  • 16. [Morphological observation on NK/LAK cell-mediated lysis of human oral carcinoma cells].
    Zheng YJ, Zhang J, Wang SM, Zhang JR.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Apr 01; 24(4):392-6. PubMed ID: 15090306
    [Abstract] [Full Text] [Related]

  • 17. Immunological surveillance against DNA-virus-transformed cells: correlations between natural killer cell cytolytic competence and tumor susceptibility of athymic rodents.
    Cook JL, Lewis AM.
    J Virol; 1987 Jul 01; 61(7):2155-61. PubMed ID: 3495670
    [Abstract] [Full Text] [Related]

  • 18. Adenovirus persistence in man. Defective E1A gene product targeting of infected cells for elimination by natural killer cells.
    Routes JM, Cook JL.
    J Immunol; 1989 Jun 01; 142(11):4022-6. PubMed ID: 2541204
    [Abstract] [Full Text] [Related]

  • 19. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F, Peri G, Villa A, Mantovani A.
    J Immunol; 1984 Feb 01; 132(2):936-44. PubMed ID: 6690624
    [Abstract] [Full Text] [Related]

  • 20. Characterization and comparison of the lytic function of NKR-P1+ and NKR-P1-rat natural killer cell clones established from NKR-P1bright/TCR alpha beta-cell lines.
    Brissette-Storkus C, Appasamy PM, Hayes LA, Kaufman CL, Ildstad ST, Chambers WH.
    Nat Immun; 1995 Feb 01; 14(2):98-113. PubMed ID: 8601077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.